Aiting Di
Overview
Explore the profile of Aiting Di including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
You W, Di A, Zhang L, Zhao G
Bioengineered
. 2022 Jan;
13(2):2586-2597.
PMID: 35037825
Wogonin is an effective component of Georgi, which exhibits anti-tumor activity. The aim of this study was to explore the effects of wogonin on colon cancer (CC). Human CC cell...
2.
You W, Xu Z, Di A, Liu P, Pang C, Wang J, et al.
Evid Based Complement Alternat Med
. 2021 Sep;
2021:5533914.
PMID: 34504536
Objective: Tong Xie Yao Fang (TXYF) is a classic and effective prescription in traditional Chinese medicine which is used to treat ulcerative colitis (UC). Our study investigated the effect of...
3.
Malaikolundhan H, Mookkan G, Krishnamoorthi G, Matheswaran N, Alsawalha M, Veeraraghavan V, et al.
Artif Cells Nanomed Biotechnol
. 2020 Oct;
48(1):1206-1213.
PMID: 33016139
Colon cancer is one of the major prevailing types of cancer worldwide. It has been the most important public health difficulty. Thus, we planned phytoconstituents arbitrated synthesis of gold nanoparticles...
4.
Qiao C, Wan J, Zhang L, Luo B, Liu P, Di A, et al.
Am J Transl Res
. 2019 Dec;
11(11):7074-7083.
PMID: 31814910
Background: Ulcerative colitis (UC) is a chronic inflammatory intestinal disease, and its morbidity is rising worldwide. Previous study indicated that astragaloside II (AS II), a monomeric compound, was used to...
5.
Wan J, Yang J, Qiao C, Sun X, Di A, Zhang L, et al.
Yonsei Med J
. 2019 Apr;
60(5):414-422.
PMID: 31016902
Purpose: Colorectal cancer (CRC) is the third most common cancer in China and poses high morbidity and mortality. In recent years, increasing evidence has indicated that microRNAs played important functions...